In contrast to our data, Vural and colleagues demonstrated higher FABP4 mRNA levels in EAT and ascending aorta of CAD patients with metabolic syndrome compared with metabolically healthy individuals (Vural et al. , 2008). This evidence concerns the gene FABP4 and coronary artery disorder.